Cytek Biosciences, Inc. CTKB Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Cytek Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytek Biosciences, Inc.'s investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytek Biosciences, Inc.'s investing cash flow?
- Cytek Biosciences, Inc. (CTKB) reported investing cash flow of -$27.08M in Q1 2026.
- How has Cytek Biosciences, Inc.'s investing cash flow changed year-over-year?
- Cytek Biosciences, Inc.'s investing cash flow decreased by 386.5% year-over-year, from $9.45M to -$27.08M.
- What is the long-term trend for Cytek Biosciences, Inc.'s investing cash flow?
- Over 2 years (2021 to 2024), Cytek Biosciences, Inc.'s investing cash flow has grown at a 101.2% compound annual growth rate (CAGR), from -$20.99M to -$85M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.